These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16554397

  • 1. Reduction in cortisol after smoking cessation among users of nicotine patches.
    Ussher M, West R, Evans P, Steptoe A, McEwen A, Clow A, Hucklebridge F.
    Psychosom Med; 2006; 68(2):299-306. PubMed ID: 16554397
    [Abstract] [Full Text] [Related]

  • 2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S.
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [Abstract] [Full Text] [Related]

  • 3. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM, Diacon AH, van Biljon X, Bolliger CT.
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
    Rezaishiraz H, Hyland A, Mahoney MC, O'Connor RJ, Cummings KM.
    Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
    [Abstract] [Full Text] [Related]

  • 6. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A.
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [Abstract] [Full Text] [Related]

  • 7. Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers.
    Frederick SL, Reus VI, Ginsberg D, Hall SM, Munoz RF, Ellman G.
    Biol Psychiatry; 1998 Apr 01; 43(7):525-30. PubMed ID: 9547932
    [Abstract] [Full Text] [Related]

  • 8. Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse.
    al'Absi M, Hatsukami D, Davis GL, Wittmers LE.
    Drug Alcohol Depend; 2004 Mar 08; 73(3):267-78. PubMed ID: 15036549
    [Abstract] [Full Text] [Related]

  • 9. Smoking, cortisol and nicotine.
    Steptoe A, Ussher M.
    Int J Psychophysiol; 2006 Mar 08; 59(3):228-35. PubMed ID: 16337291
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
    Aubin HJ, Luthringer R, Demazières A, Dupont C, Lagrue G.
    Nicotine Tob Res; 2006 Apr 08; 8(2):193-201. PubMed ID: 16766412
    [Abstract] [Full Text] [Related]

  • 11. The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program.
    Alberg AJ, Stashefsky Margalit R, Burke A, Rasch KA, Stewart N, Kline JA, Ernst PA, Avey A, Hoffman SC.
    Addict Behav; 2004 Dec 08; 29(9):1763-78. PubMed ID: 15530720
    [Abstract] [Full Text] [Related]

  • 12. Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches.
    Nørregaard J, Tønnesen P, Petersen L.
    Prev Med; 1993 Mar 08; 22(2):261-71. PubMed ID: 8483863
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB.
    Exp Clin Psychopharmacol; 2007 Feb 08; 15(1):81-92. PubMed ID: 17295587
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic-pituitary-adrenocortical responses to psychological stress and risk for smoking relapse.
    al'Absi M.
    Int J Psychophysiol; 2006 Mar 08; 59(3):218-27. PubMed ID: 16442170
    [Abstract] [Full Text] [Related]

  • 16. Salivary cortisol concentrations are associated with acute nicotine withdrawal.
    Cohen LM, al'Absi M, Collins FL.
    Addict Behav; 2004 Nov 08; 29(8):1673-8. PubMed ID: 15451136
    [Abstract] [Full Text] [Related]

  • 17. Motives for smoking and their correlates in clients attending Stop Smoking treatment services.
    McEwen A, West R, McRobbie H.
    Nicotine Tob Res; 2008 May 08; 10(5):843-50. PubMed ID: 18569758
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G, Lemmonds CA, Kotler ML, Durcan MJ, Boyle J.
    J Clin Psychopharmacol; 2008 Dec 08; 28(6):667-74. PubMed ID: 19011436
    [Abstract] [Full Text] [Related]

  • 19. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
    Rose JE, Herskovic JE, Behm FM, Westman EC.
    Nicotine Tob Res; 2009 Sep 08; 11(9):1067-75. PubMed ID: 19567826
    [Abstract] [Full Text] [Related]

  • 20. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
    Shiffman S, Ferguson SG, Strahs KR.
    Am J Prev Med; 2009 Feb 08; 36(2):96-104.e1. PubMed ID: 19135903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.